FeesSafety
Pluang+

Phillips Edison secures $350M unsecured term loan to extend debt maturity and boost growth flexibility

Company Fundamentals
26 Oct 2026, 23:18 WIB
GlobeNewsWire
View Source
Bullish
Phillips Edison secures $350M unsecured term loan to extend debt maturity and boost growth flexibility

Phillips Edison & Company closed a $350 million unsecured term loan facility with a three-year term, maturing in October 2029. The loan bears interest at SOFR plus 0.80% initially and includes an option to borrow up to $800 million in total. The company used $175 million of the loan to repay existing debt, improving its balance sheet and extending its debt maturity profile. This financing move enhances Phillips Edison's flexibility to support its growth strategy in grocery-anchored shopping centers across the U.S.

Phillips Edison & Company's recent $350 million unsecured term loan is contextually placed alongside real estate market activity on Pluang. For readers following real estate, here is Pluang's market snapshot as of Oct 27, 2026 03:21 WIB: Out of 47 priced US real estate stocks, 31 rose and 15 fell. Notable movers include PSA at USD 304.00 with a 1-day change of -1.90% and a typical hold time of 131 days, OHI at USD 47.00 up 1.67% with an 11-day hold, and HST at USD 25.10 up 1.54% also with an 11-day hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App